Skip to main content
Clinical Trials/NL-OMON22722
NL-OMON22722RecruitingNot Applicable

Sentinel Node And Recurrent Breast cancer

The principal investigator of this study is mrs. A. Maaskant-Braat, resident surgery0 sites150 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
150

Study Overview

Brief Summary

/A

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Women above 18 years old with locally recurrent breast cancer after earlier BCT or modified radical mastectomy.
  • 2. Operable cytological /histological confirmed locally recurrent breast cancer.

Exclusion Criteria

  • 1. Proven ipsi- or contralateral regional lymph node metastases (ultrasound and FNA).
  • 2. Known to be allergic to 99mTc-colloidal albumin” or blue dye injection fluids.

Investigators

Sponsor
The principal investigator of this study is mrs. A. Maaskant-Braat, resident surgery

Similar Trials

Sentinel Node And Recurrent Breast cancer | Clinical Trial